# Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

> **NCT02500849** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- HIV

## Interventions

- **GENETIC:** SB-728mR-HSPC Infusion 3 days following busulfan conditioning

## Key facts

- **NCT ID:** NCT02500849
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-03-10
- **Primary completion:** 2026-08-24
- **Final completion:** 2026-08-24
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02500849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02500849, "Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02500849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*